Chronic modafinil effects on drug-seeking following methamphetamine self-administration in rats.
Chronic modafinil effects on drug-seeking following methamphetamine self-administration in rats.
复制标题
DOI:
10.1017/s1461145711000988
复制
发表时间:
2012-08
期刊:
影响因子:
--
通讯作者:
See RE
中科院分区:
文献类型:
--
作者:
Reichel CM;See RE
Acute administration of the cognitive enhancing drug, modafinil (Provigil®), reduces methamphetamine (meth) seeking following withdrawal from daily self-administration. However, the more clinically relevant effects of modafinil on meth-seeking after chronic treatment have not been explored. Here, we determined the impact of modafinil on meth-seeking after chronic daily treatment during extinction or abstinence following meth self-administration. Rats self-administered intravenous meth during daily 2-h sessions for 14 days, followed by extinction sessions or abstinence. During this period, rats received daily injections of vehicle, 30, or 100 mg/kg modafinil and were then tested for meth-seeking via cue, meth-primed, and context-induced reinstatement at early and late withdrawal time points. We found that chronic modafinil attenuated relapse to a meth-paired context, decreased conditioned cue-induced and meth-primed reinstatement, and resulted in enduring reductions in meth-seeking even after discontinuation of treatment. Additionally, we determined that only a very high dose of modafinil (300 mg/kg) during maintenance of self-administration had an impact on meth intake. These results validate and extend clinical and preclinical findings that modafinil may be a viable treatment option for meth addiction.